Skip to main content
. 2020 Nov 20;60(6):2725–2734. doi: 10.1093/rheumatology/keaa692

Fig. 4.


Fig. 4

Incidence rate ratios (SpA subtype vs matched controls) with 95% CI for each extra-articular manifestation